{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:37:39Z","timestamp":1791920259375,"version":"4.3.4"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016966","name":"Bethune Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016966","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Non-obese non-alcoholic fatty liver disease (NAFLD) phenotype has sparked interest and frequently occurred in type 2 diabetes mellitus (T2DM). Information on associations between lipid parameters and NAFLD in non-obese patients with diabetes has been lacking. We aimed to investigate the relationships between lipid parameters and NAFLD according to obesity status and metabolic goal achievement in T2DM patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 1,913 T2DM patients who were hospitalized between June 2018 and May 2021 were cross-sectionally assessed. We used logistic regression models to estimate the associations of lipid parameters with NAFLD risk according to obesity and metabolic goal achievement status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Higher triglycerides, non-HDL-cholesterol, and all lipid ratios including (total cholesterol\/HDL-cholesterol, triglyceride\/HDL-cholesterol, LDL-cholesterol\/HDL-cholesterol, non-HDL-cholesterol\/HDL-cholesterol), and lower HDL-cholesterol were associated with NAFLD risk in both non-obese and obese patients. The associations were stronger in non-obese patients than in obese patients. Further, the inverse associations of total cholesterol and LDL-cholesterol with NAFLD risk were only detected in non-obese patients. Triglycerides, HDL-cholesterol, and all lipid ratios studied were significantly associated with NAFLD risk, irrespective of whether the patients achieved their HbA1c, blood pressure, and LDL-cholesterol goal. The presence of poor lipids and lipid ratios were more strongly associated with NAFLD in patients who attained the HbA1c, blood pressure, and\/or LDL-cholesterol goal than in those who did not achieve the goal attainment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The associations of lipids and lipid ratios with NAFLD risk were stronger in T2DM patients who were non-obese and achieved the HbA1c, blood pressure, and\/or LDL-cholesterol goal attainment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2022.1002099","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T01:52:25Z","timestamp":1663293145000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Associations of lipid parameters with non-alcoholic fatty liver disease in type 2 diabetic patients according to obesity status and metabolic goal achievement"],"prefix":"10.3389","volume":"13","author":[{"given":"Zengzhe","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat Rev Gastro Hepat"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23789","article-title":"Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data","volume":"52","author":"Ghouri","year":"2010","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1358519","article-title":"Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease","volume":"33","author":"Cohen","year":"2013","journal-title":"Semin Liver Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23593","article-title":"Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The framingham heart study","volume":"51","author":"Speliotes","year":"2010","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jacl.2015.12.026","article-title":"Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol","volume":"10","author":"Wu","year":"2016","journal-title":"J Clin Lipidol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12944-019-0986-7","article-title":"Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study","volume":"18","author":"Fan","year":"2019","journal-title":"Lipids Health Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2014.01.010","article-title":"Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents","volume":"24","author":"Pacifico","year":"2014","journal-title":"Nutr Metad Cardiovas"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10020270","article-title":"Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome","volume":"10","author":"Rinaldi","year":"2021","journal-title":"A Narrative Rev Antioxid"},{"key":"B11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.37349\/emed.2020.00019","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin","volume":"1","author":"Acierno","year":"2020","journal-title":"Explor Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/pr9010135","article-title":"Non-alcoholic fatty liver disease: From pathogenesis to clinical impact","volume":"9","author":"Caturano","year":"2021","journal-title":"Processes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15353","article-title":"A review of non-alcoholic fatty liver disease in non-obese and lean individuals","volume":"36","author":"Ahadi","year":"2021","journal-title":"J Gastroen Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2022","journal-title":"Lancet Gastroenterol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.235","article-title":"Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: A population study using proton-magnetic resonance spectroscopy","volume":"110","author":"Wei","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.08.028","article-title":"Nonobese fatty liver disease","volume":"15","author":"Kim","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2015.11.017","article-title":"The associations between apolipoprotein b, A1, and the B\/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population","volume":"10","author":"Yang","year":"2016","journal-title":"J Clin Lipidol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0645","article-title":"Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis","volume":"38","author":"Mackey","year":"2015","journal-title":"Diabetes Care"},{"key":"B19","first-page":"5","article-title":"Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population","volume":"23","author":"Zhou","year":"2002","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.146019","article-title":"Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease","volume":"57","author":"Harrison","year":"2008","journal-title":"Gut"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/endrev\/bnac018","article-title":"Glucagon-like peptide-1 receptor-based therapeutics for metabolic liver disease","author":"Yabut","year":"2022","journal-title":"Endocr Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108025","article-title":"Metformin: An old drug against old age and associated morbidities","volume":"160","author":"Salvatore","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12977","article-title":"Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study","volume":"36","author":"Fukuda","year":"2016","journal-title":"Liver Int"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.03.016","article-title":"Beyond high-density lipoprotein cholesterol levels","volume":"51","author":"deGoma","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0021-9150(01)00651-7","article-title":"HDL and arteriosclerosis: beyond reverse cholesterol transport","volume":"161","author":"Nofer","year":"2002","journal-title":"Atherosclerosis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.112.035758","article-title":"Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the international study of prediction of intra-abdominal adiposity and its relationship with cardiometabolic Risk\/Intra-abdominal adiposity","volume":"96","author":"Nazare","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2016.06.006","article-title":"Lipid phenotypes in patients with nonalcoholic fatty liver disease","volume":"65","author":"Du","year":"2016","journal-title":"Metabolism"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2018-101119","article-title":"Non-alcoholic fatty liver disease (NAFLD) in non-obese individuals","volume":"11","author":"Phipps","year":"2020","journal-title":"Frontline Gastroente"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/3920196","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","volume":"2022","author":"Tanase","year":"2020","journal-title":"J Diabetes Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22350","article-title":"Visceral fat: A key mediator of steatohepatitis in metabolic liver disease","volume":"48","author":"van der Poorten","year":"2008","journal-title":"Hepatology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyl245","article-title":"Why might south asians be so susceptible to central obesity and its atherogenic consequences? the adipose tissue overflow hypothesis","volume":"36","author":"Sniderman","year":"2007","journal-title":"Int J Epidemiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: The state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13455","article-title":"Mean and visit-to-visit variability of glycated hemoglobin, and the risk of non-alcoholic fatty liver disease","volume":"12","author":"Yoo","year":"2021","journal-title":"J Diabetes Invest"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000532","article-title":"Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk","volume":"33","author":"Aneni","year":"2015","journal-title":"J Hypertens"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2021.20641","article-title":"Systolic blood pressure mediates body mass index and non-alcoholic fatty liver disease: A population-based study","volume":"32","author":"Guan","year":"2021","journal-title":"Turk J Gastroenterol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013781","article-title":"Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study","volume":"6","author":"Sun","year":"2016","journal-title":"BMJ Open"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115403","article-title":"LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: A multicenter cross-sectional study","volume":"9","author":"Imajo","year":"2014","journal-title":"PloS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cgh.2014.10.008","article-title":"Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile","volume":"13","author":"Siddiqui","year":"2015","journal-title":"Clin Gastroenterol H"},{"key":"B43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/DMSO.S229590","article-title":"Novel application of the traditional lipid ratios as strong risk predictors of NASH","volume":"13","author":"Hegazy","year":"2020","journal-title":"Diabetes Metab Synd OB"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3111","article-title":"Hepatic steatosis and insulin resistance, but not steatohepatitis, promote atherogenic dyslipidemia in NAFLD","volume":"101","author":"Bril","year":"2016","journal-title":"J Clin Endocr Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1002099\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T01:52:32Z","timestamp":1663293152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1002099\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":45,"alternative-id":["10.3389\/fendo.2022.1002099"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1002099","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"article-number":"1002099"}}